Robert Howard Lewin
Analyst · Ben Budish with Barclays
Thanks a lot, Craig, and thanks to everyone for joining our call this morning. As Craig just walked through, our model continues to deliver consistent results. I'd like to begin by highlighting our deployment and monetization activity, which demonstrates the strength of our global and diversified platform. KKR has been around now for 49 years and has navigated a range of macroeconomic backdrops over those 5 decades. We understand that volatility and uncertainty create opportunity and have positioned our firm to ensure that we are maximizing that opportunity on behalf of our clients. We build portfolios for the very long term. And when you invest in companies and assets for 5- to 10-plus-year horizons, you need to be thoughtful about how the world is going to evolve. And we have found it less important to try and time the market. It is why we are so disciplined in linear deployment and creating outperformance through our approach to value creation at the asset level. Since the start of the year, we've deployed nearly $37 billion of capital with around half of that deployed in the second quarter. Within private markets, nearly 50% of our year-to-date activity has been outside of the U.S., and we've been balanced in deploying capital across traditional private equity, growth equity, infrastructure and real estate. In Credit, we've deployed $18 billion of alternative capital since January, diversified largely across direct lending and asset-based finance. ABF in particular is an area where we continue to see a lot of growth opportunity, which I'll touch on in a bit more detail in a few minutes. Importantly, there remains a healthy pipeline for deployment in the second half of 2025, and we feel well positioned with $115 billion of uncalled capital. As a result of this consistent approach to investing, we also have a mature portfolio that we can monetize opportunistically. Over the last 12 months, realized performance and investment income totaled $2.6 billion. That number is up over 20% from the same period a year ago. Even with that healthy momentum on monetizations, our unrealized carried interest across our global portfolio today stands at a record $9.2 billion. And that number is up roughly 30% from $7.1 billion just 12 months ago. Looking at our private equity portfolio specifically. Approximately 60% is marked at over 1.5x our cost. And on average, our public names are marked at over 5x our cost. So our portfolio is in very good shape. And ultimately, that is the most important indicator of future monetizations. I would say that it is really our global footprint that is a large driver of the continued deployment and monetization activity that we are seeing across the firm. As an example, we've seen robust activity out of Asia recently where we have 9 offices, nearly 600 executives and manage over $75 billion of assets. Over the past 20 years, we've built a very large localized business, and we've grown and diversified. Today, traditional private equity comprises less than half of our Asia AUM. That's compared to approximately 90% in 2019. Just to give you a sense of our activity here, we recently signed a definitive agreement to exit an investment in a pharmaceutical company in India, closed on our previously announced exits of a telecom tower company in the Philippines and a grocery store chain in Japan, invested in a leading agricultural infrastructure business in Australia and a new financial services platform in Singapore and established a battery energy storage joint venture in Korea. As you can hear, we got a lot going on across Asia and really continue to be at the forefront of activity in the region. To close out my remarks this morning on monetization. If you take a look at our pending monetization as we head into the second half of 2025, so transactions that are signed but not yet closed. We have direct line of sight to north of $800 million of monetization-related revenue, the vast majority of which will be performance income. This is a healthy figure for us and consistent with the overall health of our portfolio. Now turning to the fundraising environment and a few other notable items for the quarter. In Q2, we raised $28 billion of capital and continue to see meaningful progress across asset classes. We held a final close in the second vintage of our asset-based finance drawdown fund and parallel separately managed accounts, with a total of $6.5 billion in commitments. This is more than triple the $2.1 billion predecessor pool of capital. The composition of investors in the fund is encouraging with approximately 50% of limited partners new to the KKR Credit platform and commitments are roughly evenly split across clients from the U.S., Europe and Asia. More broadly, our ABF business continues to see meaningful growth with AUM increasing over 20% from this time last year to $75 billion. We see ABF as a $6 trillion addressable market today, increasing to over $9 trillion over the next 4 years. The alternative credit ecosystem overall, including not only ABF, but also direct lending and capital solutions, is now larger than the traditional high- yield and leveraged loan markets combined. So ABF is a growing market with secular tailwinds for our industry, and we believe that we are already a leader in the space today. In Real Assets, we've begun raising capital for our Asia infrastructure strategy. And as we think about demand, we feel encouraged by our historical success in this asset class and the differentiated investment returns that we've been able to achieve as well as the depth of our Pan-Asian presence and breadth of our global connectivity. Turning to wealth. K-Series AUM was $25 billion across private equity, infrastructure, real estate and credit as of June 30, that figure compares to $11 billion just a year ago. We've been really pleased here to see inflows continue to track at or ahead of our expectations despite the market volatility that we've experienced year-to-date. As you know, in April, we launched 2 public private solutions through our strategic partnership with Capital Group, making the KKR platform available to an even broader universe of clients. Our continued momentum is earmarked most recently with the filing of a registration statement with the SEC for a public private equity product, which on the private side will be investing in a K-Series private equity vehicle as well as PE co-invest opportunities. And looking ahead, we continue to work on a real asset product. We feel great about our partnership with Capital Group and believe that there is more to do together as partners. Next, I'd like to give a brief update on our insurance business. First, with a focus on elongating and further diversifying our liabilities. Over the last 4 months, we successfully issued approximately $2.5 billion of funding agreements with a weighted average duration of 8 years through separate transactions in the U.S., Europe, Japan and Canada. We believe the local currency liability funding will also help support asset origination outside of the U.S. And you should expect us to continue to be active here with a real focus on the longer duration parts of the FABN market. Alongside of this, we continue to make very good progress on the addition of alternatives to the portfolio where we believe that we have a differentiated sourcing advantage as a firm. We expect these changes will ultimately drive up overall returns, while at the same time, naturally reducing our leverage profile. And second, an update on third-party capital, which is a critical component of our strategy at Global Atlantic. Earlier this week, Japan Post Insurance announced that it would invest $2 billion through a new vehicle managed by Global Atlantic, expanding our existing strategic partnership. As we have talked about since our initial purchase of Global Atlantic, our ability to marry third-party capital alongside the GA balance sheet is a real differentiator for us. Our Ivy sidecar vehicles, which pay fee and carry similar to a drawdown credit or PE fund, allow us to grow GA in a very capital-efficient way. More specific to the Japan Post commitment. This is another milestone in that effort. And when you aggregate the JPI commitment and where we stand on our Ivy strategy capital raise, we currently have approximately $6 billion of third-party capital capacity versus Ivy II, which was at $2.7 billion. Once this new capital is put to work, we expect it will translate to over $60 billion of additional fee- paying AUM. So we are seeing significant momentum and an important part of our strategy and are pleased by the receptivity of our client base to insurance as a new and compelling asset class. The last item I wanted to touch on is more of a strategic update. Yesterday, we announced an expansion of our life sciences footprint through the acquisition of a majority stake in HealthCare Royalty Partners or HCR, a leader in biopharma royalty investing. The company's total AUM of approximately $3 billion is largely perpetual in nature. As part of this transaction, HCR's approximately 30 employees will continue to focus on royalties and credit investing opportunities and will collaborate closely with KKR's existing teams. HCR builds on KKR's long-standing experience in health care investing across traditional private equity and middle market funds, our dedicated health care strategic growth strategy as well as our existing strategic investment in Catalio Capital. This acquisition is also very consistent with our framework for evaluating strategic asset manager M&A. HCR brings us long duration, unique and largely perpetual capital, access to large addressable markets where HCR is already a top 3 player. And importantly, we believe that HCR will bring additional origination capacity to our overall platform, primarily across Global Atlantic and our credit pools of capital. Thank you all for joining our call this morning. Our team remains very excited around the business momentum that we are seeing across the firm. And importantly, how that will translate into further P&L outcomes. And to be clear, given all of this momentum, we continue to feel confident in our ability to achieve the 2026 guidance that we shared last year across both our fundraising and our core financial metrics which include FRE per share, TOE per share and, of course, ANI per share. And now before we move on to questions, I'd like to briefly hand it off to Scott.